Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Resveratrol differentially modulates inflammatory responses of microglia and astrocytes
  2. Lu, X. F.; Ma, L. L.; Ruan, L. F.; Kong, Y.; Mou, H. W.; Zhang, Z. J.; Wang, Z. J.; Wang, J. M.; Le, Y. Y.
  3. Journal of Neuroinflammation. 2010, Aug; 7: 14.
  1. 2.   Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice
  2. Hwang, S. K.; Jin, H.; Kwon, J. T.; Chang, S. H.; Kim, T. H.; Cho, C. S.; Lee, K. H.; Young, M. R.; Colburn, N. H.; Beck, G. R.; Yang, H. S.; Cho, M. H.
  3. Gene Therapy. 2007, Sep; 14(18): 1353-1361.
  1. 3.   Natural products from marine invertebrates and microbes as modulators of antitumor targets
  2. Newman, D. J.; Cragg, G. M.
  3. Current Drug Targets. 2006, MAR; 7(3): 279-304.
  1. 4.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 5.   Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
  2. Youn, H. S.; Lee, J. Y.; Fitzgerald, K. A.; Young, H. A.; Akira, S.; Hwang, D. H.
  3. Journal of Immunology. 2005, SEP 1; 175(5): 3339-3346.
  1. 6.   Linking tumor cell cytotoxicity to mechanism of drug action: An integrated analysis of gene expression, small-molecule screening and structural databases
  2. Covell, D. G.; Wallqvist, A.; Huang, R. L.; Thanki, N.; Rabow, A. A.; Lu, X. J.
  3. Proteins-Structure Function and Bioinformatics. 2005, MAY 15; 59(3): 403-433.
  1. 7.   A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors
  2. Daelemans, D.; Pannecouque, C.; Pavlakis, G. N.; Tabarrini, O.; De Clercq, E.
  3. Molecular Pharmacology. 2005, MAY; 67(5): 1574-1580.
  1. 8.   Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-Lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis
  2. Nellis, D. F.; Giardina, S. L.; Janini, G. M.; Shenoy, S. R.; Marks, J. D.; Tsai, R.; Drummond, D. C.; Hong, K.; Park, J. W.; Ouellette, T. F.; Perkins, S. C.; Kirpotin, D. B.
  3. Biotechnology Progress. 2005, JAN-FEB; 21(1): 221-232.
  1. 9.   The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen- activated protein kinase activity
  2. Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Mihalic, K.; Xiao, W. H.; Farrar, W. L.
  3. Cancer Research. 2003 63(9): 2046-2051.
  1. 10.   wmc79 and hkh40a - Potent agents against gastrointestinal cancers: Molecular targets and mechanism of action
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Hariprakasha, H. K.; Michejda, C. J.; Hollingshead, M. G.; Pommier, Y.; Antony, S.; Kar, S.; Carr, B. I.
  3. Clinical Cancer Research. 2003 9(16): 6077S-6078S.
  1. 11.   Natural product drug discovery in the next millennium
  2. Cragg, G. M.; Newman, D. J.
  3. Pharmaceutical Biology. 2001 39(Suppl. S): 8-17.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel